An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
Bariatrics at USA Health
Bariatrics is the branch of medicine devoted to treating and preventing obesity. At USA Health, we specialize in surgical treatments for obesity that include laparascopic gastric bypass and laparascopic gastric sleeve procedures.